상급종합병원 비대면 진료 재이용에 영향을 미치는 요인

Factors Affecting the Reuse of Non-face-to-face Treatment by Non-face-to-face Treatment Patients in Tertiary General Hospital

  • 민선영 (연세대학교 보건대학원 의료경영학과) ;
  • 김태현 (연세대학교 보건대학원 의료경영학과) ;
  • 이상규 (연세대학교 보건대학원 의료경영학과) ;
  • 장석용 (연세대학교 보건대학원 의료경영학과)
  • Sun-Young Min ( Department of Healthcare Management, Graduate School of Public Health, Yonsei University) ;
  • Tae Hyun Kim ( Department of Healthcare Management, Graduate School of Public Health, Yonsei University) ;
  • Sang Gyu Lee ( Department of Healthcare Management, Graduate School of Public Health, Yonsei University) ;
  • Suk-Yong Jang ( Department of Healthcare Management, Graduate School of Public Health, Yonsei University)
  • 투고 : 2023.08.23
  • 심사 : 2023.11.16
  • 발행 : 2023.12.30

초록

Purposes: The purpose of this study is to identify and analyze the factors that affect patients reusing non-face-to-face treatments at tertiary general hospitals. Methodology: We retrospectively analyzed a patient's reuse of non-face-to-face treatment from February 1, 2020, to December 31, 2021, at a tertiary general hospital in Seoul within one year of the first non-face-to-face treatment. A frequency analysis was conducted to identify the study subjects' demographic characteristics, treatment type characteristics, disease characteristics, and hospital use type characteristics. Also, across-analysis was conducted to verify the difference in non-face-to-face treatment reuse according to the characteristics a multiple logistic regression analysis was conducted to identify the factors affecting the reuse of non-face-to-face treatment by non-face-to-face treatment patients. Findings: The results of this study can be interpreted as indicating that the following groups are more likely tore use the non-face-to-face treatment: women, children, the elderly, Patients living far from the hospital, psychiatric patients, pediatric patients, medical benefits recipients, chronic patients, patients with mobility difficulties, and patients with high loyalty to hospitals. Practical Implications: When developing a non-face-to-face treatment system in the future, based on the results of this study, it is possible to target patients who prefer non-face-to-face treatment. And this study will be research material for vitalizing non-face-to-face treatment. In addition, the activation of the non-face-to-face treatment system will be an effective means for improving the quality of medical services and generating profits in hospitals in the future.

키워드

참고문헌

  1. Chang JE, Lai AY, Gupta A, Nguyen AM, Berry CA, Shelley DR. Rapid Transition to Telehealth and the Digital Divide: Implications for Primary Care Access and Equity in a Post-COVID Era. Milbank Q 2021;99(2):340-68. https://doi.org/10.1111/1468-0009.12509
  2. Perrin PB, Pierce BS, Elliott TR. COVID-19 and telemedicine: A revolution in healthcare delivery is at hand. Health Sci Rep 2020;3(2):e166. https://doi.org/10.1002/hsr2.166
  3. Latifi R, Doarn CR. Perspective on COVID-19: Finally, Telemedicine at Center Stage. Telemed J E Health 2020;26(9):1106-9. https://doi.org/10.1089/tmj.2020.0132
  4. Kruse C, Heinemann K. Facilitators and Barriers to the Adoption of Telemedicine During the First Year of COVID-19: Systematic Review. J Med Internet Res 2022;24(1):e31752. https://doi.org/10.2196/31752
  5. Ministry of Health and Welfare. Temporary Allowance of Telephone Consultation, Prescription, and Proxy Prescription(Ministry of Health and Welfare Notice No. 2020-177). March 2, 2020.
  6. Ministry of Health and Welfare. For three years of non-face-to-face treatment, we protected the health of 13.79 million people. 86.1% of clinic-level medical institutions and 81.5% of repeat examinations (Ministry of Health and Welfare press release). March 13, 2023.
  7. Choi Y. A Study on the Introduction of Telemedicine - Coronavirus Disease 2019 and the Need for the Introduction of Telemedicine. International Law Review 2020;12(1):113-37. https://doi.org/10.36727/JJILR.12.1.202005.005
  8. Yoo SH. Non-face-to-face treatment, what is the problem and how to prepare. Research Institute for Healthcare Policy Korean Medical Association 2022;20(1):34-42.
  9. Ministry of Health and Welfare. Information on the implementation of the non-face-to-face treatment pilot project(Ministry of Health and Welfare Public Notice No. 2023-412). May 30, 2023.
  10. Kim JS, Lim SM. A Comparative Analysis on Current Status of Telemedicine Policy before and after COVID-19 : Focused on France and Australia. The Journal of Convergence Society and Public Policy 2022;16(3):129-60. https://doi.org/10.37582/CSPP.2022.16.3.129
  11. Kim JY, Lee KI. Advantages and Necessities of Telehealth Care Service. Korean J Med 2020;95(4): 217-27. https://doi.org/10.3904/kjm.2020.95.4.217
  12. Medical Service Act. Law No. 34(1) (June 30, 2021)
  13. Yoo HR, Kim S, Park C-S, Kim J-A. Perception and Satisfaction of Healthcare Providers at Hospitals on Temporarily Permitted Telephone Consultations during COVID-19 Pandemic. HIRA Research 2021;1(1):36-49. https://doi.org/10.52937/hira.21.1.1.36
  14. World Health Organization. Global diffusion of eHealth: making universal health coverage achievable: report of the third global survey on eHealth. 2016.
  15. Benis A, Banker M, Pinkasovich D, Kirin M, Yoshai B-e, Benchoam-Ravid R, et al. Reasons for utilizing telemedicine during and after the COVID-19 pandemic: an internet-based international study. J Clin Med 2021;10(23):5519. https://doi.org/10.3390/jcm10235519
  16. Kang E, Lee H, Hong KJ, Yun J, Lee JY, Hong YC. The general public's perspectives on telemedicine during the COVID-19 pandemic in Korea: analysis of a nationwide survey. Epidemiol Health. 2022;44:e2022020. https://doi.org/10.4178/epih.e2022020
  17. Kim HS. COVID-19 Case Surge and Tele- medicine Utilization in A Tertiary Hospital in Korea [dissertation]. Seoul: Yonsei University; 2021.
  18. Tzeng YH, Yin WH, Lin KC, Wei J, Liou HR, Sung HJ, et al. Factors Associated With the Utilization of Outpatient Virtual Clinics: Retrospective Observational Study Using Multilevel Analysis. J Med Internet Res 2022;24(8): e40288. https://doi.org/10.2196/40288
  19. Eberly LA, Kallan MJ, Julien HM, Haynes N, Khatana SAM, Nathan AS, et al. Patient Characteristics Associated With Telemedicine Access for Primary and Specialty Ambulatory Care During the COVID-19 Pandemic. JAMA Netw Open 2020;3(12):e2031640. https://doi.org/10.1001/jamanetworkopen.2020.31640
  20. Lanier K, Kuruvilla M, Shih J. Patient satisfaction and utilization of telemedicine services in allergy: an institutional survey. The Journal of Allergy and Clinical Immunology: In Practice  2021;9(1):484-6. https://doi.org/10.1016/j.jaip.2020.09.047
  21. Narcisse MR, Andersen JA, Felix HC, Hayes CJ, Eswaran H, McElfish PA. Factors associated with telehealth use among adults in the United States: Findings from the 2020 National Health Interview Survey. J Telemed Telecare 2022;0(0): 1357633X221113192.
  22. Reed ME, Huang J, Graetz I, Lee C, Muelly E, Kennedy C, et al. Patient Characteristics Associated With Choosing a Telemedicine Visit vs Office Visit With the Same Primary Care Clinicians. JAMA Netw Open 2020;3(6):e205873. https://doi.org/10.1001/jamanetworkopen.2020.5873
  23. Polinski JM, Barker T, Gagliano N, Sussman A, Brennan TA, Shrank WH. Patients' Satisfaction with and Preference for Telehealth Visits. J Gen Intern Med 2016;31(3):269-75. https://doi.org/10.1007/s11606-015-3489-x
  24. Vosburg RW, Robinson KA. Telemedicine in primary care during the COVID-19 pandemic: provider and patient satisfaction examined. Telemed J E Health 2022;28(2):167-75. https://doi.org/10.1089/tmj.2021.0174
  25. Choi NG, DiNitto DM, Marti CN, Choi BY. Telehealth Use Among Older Adults During COVID-19: Associations With Sociodemographic and Health Characteristics, Technology Device Ownership, and Technology Learning. J Appl Gerontol 2022;41(3):600-9. https://doi.org/10.1177/07334648211047347
  26. Saxena V, Bahurupi Y, Mishra A, Singh A, Parate S, Sandhu H. Strength, weakness, opportunities, and threats (SWOT) analysis of virtual outpatient department under telemedicine department during the COVID-19 pandemic. Cureus 2022;14(2).
  27. Engel J, Kollat D, Blackwell R. Consumer Behavior Holt. New York: Rinehart and Winston Marketing Series. 1968.
  28. Oliver RL, Bearden WO. Disconfirmation processes and consumer evaluations in product usage. J Bus Res 1985;13(3):235-46. https://doi.org/10.1016/0148-2963(85)90029-3
  29. Berry LL, Carbone LP. Build loyalty through experience management. Qual Prog 2007;40(9):26.
  30. Reichheld FF. Loyalty-based management. Harv Bus Rev 1993;71(2):64-73.
  31. Naumann E, Giel K. Customer satisfaction measurement and management: Using the voice of the customer: Van Nostrand Reinhold; 1995.
  32. Zeithaml VA, Berry LL, Parasuraman A. The behavioral consequences of service quality. J Mark 1996;60(2):31-46. https://doi.org/10.1177/002224299606000203
  33. World Health Organization. Telemedicine, Global Observatory for eHealth series 2010;2:8-9.
  34. Baek KH, Park SJ. A Study on whether telemedicine is permitted and its scope during the pendemic. KOOKMIN LAW REVIEW 2020;48:341-69.
  35. Kim JS, Oh SH, Kim SY, Lee PS. Telemedicine policy status analysis research. Research Institute for Healthcare Policy 2015;1-216.
  36. Park JH. Telemedicine use cases in major countries amid COVID-19. Korea Insurance Research Institute report global issue 2020;(500);20-2.
  37. Kim DH. Considerations on Untact Healthcare, Another Name for Telemedicine. Korean J Med 2020;95(4):228-31. https://doi.org/10.3904/kjm.2020.95.4.228
  38. Yoo TW. The advent of the telemedicine era. J Korean Med Assoc 1997;40(12):1687-95. https://doi.org/10.5124/jkma.1997.40.12.1687
  39. Ji S-I. In the era of COVID-19, is telemedicine necessary. Researc h Institute for Healthcare Policy Korean Medical Association 2020;18(3):87-91.
  40. Kang JH, Kim JS. Telemedicine Status in Japan: Implications for Korea. J Korean Med Assoc 2022;65(12):850-5. https://doi.org/10.5124/jkma.2022.65.12.850
  41. Kim DJ, Moon SY, Kwon YJ. Discrete choice experiment to measure consumer preference for the policy attributes of telehealth. Korea Institute for Health and Social Affairs 2022(3).
  42. Kim JY. Non-face-to-face era, domestic and international status of non-face-to-face medical care and development direction. Korea Institute of S&T Evaluation and Planning issue paper 2020;10(288).
  43. Kinoshita S, Cortright K, Crawford A, Mizuno Y, Yoshida K, Hilty D, et al. Changes in telepsychiatry regulations during the COVID-19 pandemic: 17 countries and regions' approaches to an evolving healthcare landscape. Psychol Med 2022;52(13):2606-13. https://doi.org/10.1017/S0033291720004584
  44. Kim JS. Non-face-to-face treatment, how will the medical community respond. Research Institute for Healthcare Policy Korean Medical Association 2020;18(4):35-41.
  45. Yun KJ. Changes and Tasks in Korea's Healthcare System in Times of the Covid-19 Pandemic Health Welf Policy Forum 2020;2020(12):34-49.
  46. Korea Disease Control and Prevention Agency. Lowering the COVID-19 crisis level and shifting major quarantine measures (KCDC press release). May 31, 2023.
  47. Choi SG. The Effects of Reimbursement Policy Change for Revisiting Outpatients with Hypertension and Diabetes at Tertiary Care Hospitals, Focusing on the Impact on the Volume and Expenses of Medical Services[dissertation]. Seoul: Yonsei University; 2022.
  48. Kotler P, Armstrong G. Principles of Marketing, eight edition. Prentice Hall International, New Jersey; 1999.
  49. Luo J, Tong L, Crotty BH, Somai M, Taylor B, Osinski K, et al. Telemedicine adoption during the COVID-19 pandemic: gaps and inequalities. Appl Clin Inform 2021;12(04):836-44. https://doi.org/10.1055/s-0041-1733848
  50. Ferucci ED, Holck P, Day GM, Choromanski TL, Freeman SL. Factors Associated With Use of Telemedicine for Follow-up of Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2020;72(10):1404-9. https://doi.org/10.1002/acr.24049
  51. Satin AM, Shenoy K, Sheha ED, Basques B, Schroeder GD, Vaccaro AR, et al. Spine patient satisfaction with telemedicine during the COVID-19 pandemic: a cross-sectional study. Global Spine J 2022;12(5):812-9. https://doi.org/10.1177/2192568220965521
  52. Unsworth J, Mode A. Preventing falls in older people: risk factors and primary prevention through physical activity. Br J Community Nurs 2003;8(5):214-20. https://doi.org/10.12968/bjcn.2003.8.5.11200
  53. Korean Society of Infectious Diseases and Korea Centers for Disease Control and Prevention. Analysis on 54 Mortality Cases of Coronavirus Disease 2019 in the Republic of Korea from January 19 to March 10, 2020. J Korean Med Sci 2020;35(12):e132. https://doi.org/10.3346/jkms.2020.35.e132
  54. Ruberto RA, Schweppe EA, Ahmed R, Swindell HW, Cordero CA, Lanham NS, et al. Disparities in Telemedicine Utilization During COVID-19 Pandemic: Analysis of Demographic Data from a Large Academic Orthopaedic Practice. JB JS Open Access 2022;7(2).
  55. Douglas MD, Xu J, Heggs A, Wrenn G, Mack DH, Rust G. Assessing telemedicine utilization by using Medicaid claims data. Psychiatric Services 2017;68(2):173-8. https://doi.org/10.1176/appi.ps.201500518
  56. Reiners F, Sturm J, Bouw LJW, Wouters EJM. Sociodemographic Factors Influencing the Use of eHealth in People with Chronic Diseases. Int J Environ Res Public Health 2019;16(4).
  57. Corrigan P. How stigma interferes with mental health care. Am Psychol 2004;59(7):614. https://doi.org/10.1037/0003-066X.59.7.614
  58. Chakrabarti S. Usefulness of telepsychiatry: A critical evaluation of videoconferencing-based approaches. World J Psychiatry 2015;5(3):286. https://doi.org/10.5498/wjp.v5.i3.286
  59. Hubley S, Lynch SB, Schneck C, Thomas M, Shore J. Review of key telepsychiatry outcomes. World J Psychiatry 2016;6(2):269. https://doi.org/10.5498/wjp.v6.i2.269
  60. Moran B, Frazier T, Brown LS, Case M, Polineni S, Roy L. A Review of the Effectiveness of Audio-Only Telemedicine for Chronic Disease Management. Telemed J E Health 2022;28(9):1280-4.  https://doi.org/10.1089/tmj.2021.0285